Review Article
Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43
Table 1
Cancer-associated glycan alterations observed in the referred studies.
| Structure | Findings | References |
| T antigen | Overexpression | [14–16] | Sialyl-T antigen | Overexpression | [12, 14] | Tn antigen | Overexpression | [17–20] | Sialyl-Tn antigen | Overexpression | [17, 18, 20–22] | Sialyl-Lewisa | Overexpression | [23–27] | Sialyl-Lewisx | Overexpression | [28–30] | Core-2 | Overexpression/underexpression | [12, 31] | Core-3 | Underexpression | [12, 31] | Core-4 | Underexpression | [12, 31] | β1-6 branching of N-glycans | Overexpression | [32, 33] | Fucosylation | Overexpression | [34–37] | Sialylation | Overexpression | [38, 39] |
|
|